EGFR ANTIBODY-BASED COMBINATION THERAPY

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15854690.3

公开号：

EP3223857A1

申请日:

2015.10.30

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

EGFR antibodies can be combined to enhance their anti-cancer effect. In the present invention, at least one of two naked antibodies in a combination is provided as an antibody drug conjugate (ADC) in which the antibody is coupled with a cytotoxin. Both antibodies also can be provided in ADC form. The result is improved activity, with the improvement being synergistic in many such antibody pairs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/